Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. John Bean Technologies (JBT) initiated with a Neutral at BofA/Merrill. 2. PTC (PTC) initiated with a Buy at Benchmark. 3. Colfax (CFX) initiated with an Outperform at Credit Suisse. 4. Citizens Financial (CFG) initiated with an Underperform at Macquarie. 5. Teladoc (TDOC) initiated with an Overweight at KeyBanc. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.

Reports Q1 revenue $646.13M, consensus $637.29M. "We are pleased to report a solid start to the year, with strength in both revenue and adjusted EBITDA in the first quarter," said Mala Murthy, acting chief executive officer and chief financial officer of Teladoc Health. "During this period of transition, our team remains laser focused on our key initiatives, which include building upon our market leadership position; driving increased product penetration through our large installed base of over 90 million virtual care members; and accelerating our bottom-line performance."

Argus raised the firm's price target on Citizens Financial to $39 from $36 and keeps a Buy rating on the shares after its Q1 earnings beat. Regional bank shares have faced pressure since the failure of three regional banks amid higher deposit costs, commercial real estate exposure, and unrealized losses in the investment portfolio, but Citizens and other regional banks have adequately allayed these fears with their recent results, the analyst tells investors in a research note. Citizens has also hired a number of ex-First Republic advisors to expand its presence in the wealth management business, Argus added.